We aim to present an easily understandable version of the latest medical research on MDS
Learn about the latest research projects and use this information to discuss with your consultants or nurses: when you are actively involved in your own care, treatment and support, it can improve your outcomes and experience of the disease.
All the articles listed in this page have been properly vetted for scientific accuracy.
Watch also our Video Interviews with MDS Experts and read more on the MDS Clinical Trials currently recruiting in the UK.
More than 70 participants representing medical specialists and nurses caring for MDS patients, MDS patient advocates, medical researchers and data managers, healthcare authorities, regulators, HTA experts and industry representatives gathered for the first MDS-RIGHT multi-stakeholder meeting on the 3 May 2017 in Valencia, Spain – in conjunction with the biannual MDS 2017 International Symposium. This project […]Read full story
A new project was trialled for more than two years by nurses from home-care units in Spain: ‘Azacitidine (Vidaza) administration at home’. Now it has been rolled out to include most of the hospitals in Spain administering Azacitidine. It was initially undertaken by nurses, not necessarily haematology nurses, who would visit patients at home usually by taxi […]Read full story
The following videos come from the annual UK MDS Forum Education Day 2016, which took place in London on 11th November 2016. The day is targeted at all haematologists in the UK and Ireland who deal with MDS patients. Its aim is to provide information and updates on the most advanced scientific and clinical research […]Read full story
In this presentation from the 2016 “European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes”, Dr. Fabio Efficace discusses the importance of quality of life as a treatment goal in myelodysplastic syndromes (MDS) When latest genetic analysis and therapeutic strategies are incorporated into MDS treatment the outcomes and quality of life in patients with MDS improves.Recent research trials have incorporated […]Read full story
Researchers designed an antibody that recognises and destroys CD99-covered leukemia cells while sparing normal blood stem cellsRead full story
Research FOR PatientsFor an informed and empowered opinionand an improved consultationHave you made your clinical paper accessible yet? In order to develop new drugs to treat MDS, clinical trials are mandatory, typically testing the new drug against the treatment that is considered to be the standard at that time. However patients in clinical trials are […]Read full story
Fresher is not better It’s been long thought that when blood transfusions are needed, it may be best to use the freshest blood, but McMaster University researchers have led a large international study proving that it is not so. The study of almost 31,500 patients at six hospitals in four countries showed that having a […]Read full story
Research FOR PatientsFor an informed and empowered opinionand an improved consultationHave you made your clinical paper accessible yet? Until now, bone marrow sampling has been the primary technique for routine follow-up checks on MDS patients after initial diagnosis. The bone marrow is the heart of the disease and reveals important clues, for example, about whether […]Read full story
by Dr Mike Dennis, Consultant Haematologist, The Christie, Manchester The 57th meeting was held in Orlando, Florida (USA) in December 2015 and was attended by more than 20,000 professionals interested in blood disorders. Here is a summary of Dr Mike Dennis report. Read the full report here. Biology of MDS An increasing number of specific […]Read full story